Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)
ID: 353238Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $350K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353238

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-006.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Centers for Research in Emerging Infectious Diseases (CREID) Network through a cooperative agreement funding opportunity. This initiative aims to establish Research Centers that will enhance understanding of re-emerging and emerging infectious diseases globally, particularly in regions prone to outbreaks, utilizing a One Health approach that integrates human, animal, and environmental health. The program is critical for developing future scientists in the field and requires interdisciplinary collaboration among diverse applicants, including higher education institutions and nonprofits, with a total funding amount of $13.5 million allocated for 6-8 awards over a five-year project period. Applications are due by June 22, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AI-24-006-Full-Announcement.html
    RFA-AI-24-006.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), invites applications for the Centers for Research in Emerging Infectious Diseases (CREID) Network. This funding opportunity aims to establish Research Centers (RCs) that enhance knowledge on re-emerging and emerging infectious diseases globally, focusing on areas susceptible to outbreaks. The program requires interdisciplinary teams employing a One Health approach, emphasizing the interconnectedness of human, animal, and environmental health. Proposals must involve at least one viral pathogen from the NIAID's list of Emerging Diseases, emphasizing comprehensive research and the development of future emerging disease scientists. Each RC is responsible for flexible research capacities, outbreak response, and collaborative efforts across the CREID Network. The initiative includes a budget of $13.5 million to fund 6-8 awards, with applications due by June 22, 2024, and a project period of five years. Involvement of diverse applicants is encouraged, including higher education institutions and nonprofits, with coordination mandated among recipient organizations to optimize resources and facilitate data sharing. Substantial NIH involvement is anticipated, providing support for scientific progress and research collaboration. This initiative highlights a strategic response to global health threats posed by infectious diseases.
    Similar Opportunities
    Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Global Infectious Disease Research Training Program (D43 Clinical Trial Optional), aimed at enhancing research capacity in low- and middle-income countries (LMICs) regarding infectious diseases. This program encourages collaborative applications from U.S. and LMIC institutions, focusing on critical areas such as neglected tropical diseases and co-infections in HIV patients, while excluding HIV/AIDS as a primary focus. Successful applicants will develop structured training curricula, mentorship pairings, and research skills relevant to local health priorities, with annual budgets capped at $230,000 for a maximum project period of five years. Interested parties should note that the application deadline is August 6, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers for AIDS Research (CFAR) program, aimed at enhancing interdisciplinary HIV/AIDS research through grants. This initiative seeks to provide administrative and shared research support, fostering collaboration and infrastructure at institutions with significant NIH-funded research bases. CFARs are expected to deliver core facilities and expertise, promoting diversity, equity, and inclusion among researchers while addressing the global HIV/AIDS epidemic. Interested applicants must submit their proposals by August 4, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Environmental Health Sciences Core Centers Program (EHSCC), aimed at establishing research hubs that focus on environmental health science. This program seeks to enhance understanding of the impact of environmental exposures on human health, with an emphasis on interdisciplinary collaboration among investigators and community engagement, as outlined in the NIEHS Strategic Plan for 2025-2029. Eligible applicants include a variety of organizations such as higher education institutions and nonprofits, with a requirement for demonstrated peer-reviewed research funding of at least $3 million annually. The NIH plans to commit $6 million to fund up to four awards, with the earliest application submission date set for February 18, 2025, and a final close date of January 29, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing the Centers of Excellence in Newcomer Health
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses" (R21 - Clinical Trial Optional) aimed at supporting research into the neurological and mental health outcomes associated with chronic illnesses linked to infections, including the post-acute sequelae of COVID-19 (Neuro-PASC). The initiative encourages applications that investigate the mechanisms underlying these conditions, with a particular interest in studies that explore common pathophysiologies across various infection-associated chronic illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS). Eligible applicants include a wide range of organizations, including higher education institutions and nonprofits, with a maximum funding amount of $275,000 available for a two-year project period. Applications are due by 5:00 PM local time on November 16, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Co-infection and Cancer (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Co-infection and Cancer (R21 Clinical Trial Not Allowed)" aimed at enhancing research on the mechanisms and epidemiology of co-infections in relation to cancer development. This grant seeks innovative proposals that investigate how co-infections, particularly those involving known oncogenic agents (excluding HIV), may influence carcinogenesis and contribute to cancer disparities among diverse populations. The maximum funding amount available for each application is $275,000 over a two-year period, with applications due by November 16, 2025. Eligible applicants include a wide range of institutions and organizations, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Co-infection and Cancer (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Co-infection and Cancer (R01 Clinical Trial Not Allowed)" aimed at enhancing the understanding of infection-related cancers, particularly the roles of co-infections with multiple pathogens, excluding HIV. This initiative seeks to investigate the mechanisms and epidemiology of cancer linked to various infectious agents, addressing significant gaps in the current understanding of cancer etiology, with a focus on health disparities in underrepresented populations. Eligible applicants include a wide range of entities such as higher education institutions, nonprofits, and foreign organizations, with no budget limit for applications, although strong preliminary data is required. Key deadlines include an earliest submission date of January 5, 2025, and a close date of January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-082.html.